SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-041862
Filing Date
2013-05-15
Accepted
2013-05-15 13:19:06
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a13-7942_110q.htm 10-Q 852856
2 EX-31.1 a13-7942_1ex31d1.htm EX-31.1 9956
3 EX-31.2 a13-7942_1ex31d2.htm EX-31.2 9811
4 EX-32.1 a13-7942_1ex32d1.htm EX-32.1 6476
5 EX-32.2 a13-7942_1ex32d2.htm EX-32.2 6063
  Complete submission text file 0001104659-13-041862.txt   5775039

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ovas-20130331.xml EX-101.INS 664839
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovas-20130331.xsd EX-101.SCH 61936
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovas-20130331_cal.xml EX-101.CAL 35913
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovas-20130331_def.xml EX-101.DEF 255741
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ovas-20130331_lab.xml EX-101.LAB 911644
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovas-20130331_pre.xml EX-101.PRE 433251
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35890 | Film No.: 13845379
SIC: 2834 Pharmaceutical Preparations